Other cancers with a high expression of HIGD2A present a downward trend survival of patients, being significant for Liver hepatocellular carcinoma (LIHC) p = 0.046; Skin cutaneous melanoma (SKCM) p = 0.024; Uterine Corpus Endometrial Carcinoma (UCEC) p ≤ 0.0001; and Uveal Melanoma (UVM) p = 0.0055 (Figure 8). Here, HIGD2A is linked to cutaneous melanoma.